Asia Pacific Medical Device Analytical Testing Outsourcing Market Size & Outlook
Asia Pacific Medical Device Analytical Testing Outsourcing Market, 2018-2030 (US$M)
Global Market
Related Markets
Asia Pacific medical device analytical testing outsourcing market highlights
- The Asia Pacific medical device analytical testing outsourcing market generated a revenue of USD 1,525.2 million in 2024.
- The market is expected to grow at a CAGR of 8.9% from 2025 to 2030.
- In terms of segment, other tests was the largest revenue generating services in 2024.
- Other tests is the most lucrative services segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2030.
Asia Pacific data book summary
| Market revenue in 2024 | USD 1,525.2 million |
| Market revenue in 2030 | USD 2,533.6 million |
| Growth rate | 8.9% (CAGR from 2025 to 2030) |
| Largest segment | Other tests |
| Fastest growing segment | Other tests |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Extractable and leachable, Material characterization, Physical testing, Bioburden testing, Sterility testing, Other tests |
| Key market players worldwide | SGS AG, Labcorp Holdings Inc, Eurofins Scientific SE, Intertek Group PLC, Wuxi AppTec Co Ltd, Inotiv Inc, Charles River Laboratories International Inc, Pace Analytical Services, NAMSA, Medical Device Testing Services |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 23.3% of the global medical device analytical testing outsourcing market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,533.6 million by 2030.
Economic development in countries such as India and China is expected to boost the market growth. Multinational companies are seeking to invest in developing countries such as India and China due to increased need for affordable treatment options due to the large population with low per capita income.
Furthermore, in China, government efforts to simplify the regulatory system for foreign investors, expedite approval process for innovation, form agreements to reduce tariffs on imported hightech devices, and relax procurement controls on certain equipment are responsible for the country's nearly double-digit growth, the highest in the region.
Thus, these companies are adopting many strategies such as collaborative partnerships and strategic alliances with local companies in the region. Moreover, increasing government initiatives such as tax exemption and revamping of regulatory policies are among factors driving the market growth in Asia Pacific.
No credit card required*
Publish Date: Dec 11, 2024
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Medical Device Analytical Testing Outsourcing Market Scope
Medical Device Analytical Testing Outsourcing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Eurofins Scientific SE | View profile | 61,798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | www.eurofins.com |
| Charles River Laboratories International Inc | View profile | 21,400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | www.criver.com |
| Labcorp Holdings Inc | View profile | 67,000 | 358 South Main Street, Burlington, NC, United States, 27215 | www.labcorp.com |
| Wuxi AppTec Co Ltd | View profile | 41,116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | www.wuxiapptec.com |
| SGS AG | View profile | 103,193 | 1 Place des Alpes, P.O. Box 2152, Geneva, Switzerland, CH-1211 | www.sgs.com |
| Inotiv Inc | View profile | 2,055 | 2701 Kent Avenue, West Lafayette, IN, United States, 47906 | www.inotivco.com |
| Intertek Group PLC | View profile | 44,000 | 33 Cavendish Square, London, United Kingdom, W1G 0PS | www.intertek.com |
| Pace Analytical Services | View profile | 11-50 | Woburn, Massachusetts, United States, North America | www.pacelifesciences.com |
| NAMSA | View profile | 1001-5000 | Northwood, Ohio, United States, North America | www.namsa.com/ |
| Medical Device Testing Services | View profile | 11-50 | Minnetonka, Minnesota, United States, North America | devicetesting.com |
Asia Pacific Medical Device Analytical Testing Outsourcing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Medical Device Analytical Testing Outsourcing Market Outlook will help companies and investors design strategic landscapes.
Other Tests was the largest segment with a revenue share of 20.04% in 2024.
Horizon Databook has segmented the Asia Pacific medical device analytical testing outsourcing market based on extractable and leachable, material characterization, physical testing, bioburden testing, sterility testing, other tests covering the revenue growth of each sub-segment from 2018 to 2030.
Economic development in countries such as India and China is expected to boost the market growth. Multinational companies are seeking to invest in developing countries such as India and China due to increased need for affordable treatment options due to the large population with low per capita income.
Furthermore, in China, government efforts to simplify the regulatory system for foreign investors, expedite approval process for innovation, form agreements to reduce tariffs on imported hightech devices, and relax procurement controls on certain equipment are responsible for the country's nearly double-digit growth, the highest in the region.
Thus, these companies are adopting many strategies such as collaborative partnerships and strategic alliances with local companies in the region. Moreover, increasing government initiatives such as tax exemption and revamping of regulatory policies are among factors driving the market growth in Asia Pacific.
- Asia Pacific Medical Device Analytical Testing Outsourcing Market Services Outlook (Revenue, USD Million , 2018-2030)
- Extractable and leachable
- Material characterization
- Physical testing
- Bioburden testing
- Sterility testing
- Other tests
- Asia Pacific Medical Device Analytical Testing Outsourcing Market Therapeutic Areas Outlook (Revenue, USD Million , 2018-2030)
- Cardiology
- Diagnostic Imaging
- Orthopedic
- IVD
- Ophthalmic
- General & Plastic Surgery
- Drug Delivery
- Endoscopy
- Dental
- Diabetes Care
- Others
- Asia Pacific Medical Device Analytical Testing Outsourcing Market End Use Outlook (Revenue, USD Million , 2018-2030)
- Others
- Hospital
- Asia Pacific Medical Device Analytical Testing Outsourcing Market Device Type Outlook (Revenue, USD Million , 2018-2030)
- Others
- Reprocessed Devices
Reasons to subscribe to Medical Device Analytical Testing Outsourcing Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Medical Device Analytical Testing Outsourcing Market Outlook databook
- Our clientele includes a mix of Medical Device Analytical Testing Outsourcing Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific Medical Device Analytical Testing Outsourcing Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific Medical Device Analytical Testing Outsourcing Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Asia Pacific Medical Device Analytical Testing Outsourcing Market, 2018-2030 (US$M)
Asia Pacific medical device analytical testing outsourcing market statistics, by services, 2018-2030 (US$M)
